REN and myocardial infarction: β-Blockers and renin–angiotensin system blocking drugs may have differential benefits beyond their BP lowering effects.[42,43] Renin–angiotensin system blocking drugs confer effects on left ventricular remodeling after myocardial infarction and other vascular effects[44,45] that could influence outcomes.